Skip to main content

Table 1 Demographic and clinical characteristics of the subjects enrolled in the study.

From: IP-10 detection in urine is associated with lung diseases

 

Total

Pulmonary TB

Lung disease other than TB

Healthy subjects

Pulmonary TB after 2 mo AFB smear reversion

Pulmonary TB Cured

p value

 

N (%)

138 (100.0)

N (%)

58 (42.1)

N (%)

28 (20.3)

N (%)

34 (24.6)

N (%)

9 (6.5)

N (%)

9 (6.5)

 

Mean Age (SD)

35.87 (12.06)

32.43 (10.63)

41.89 (14.54)

38.88 (8.06)

31.60 (6.92)

32.11 (19.18)

=0.003

Female gender

48 (34.8)

18 (31.0)

8 (28.6)

16 (47.1)

1 (11.1)

5 (55.6)

=0.137

Origin

      

< 0.0001

Eastern Europe

46 (33.3)

31 (53.4)

5 (17.9)

-

4 (44.4)

6 (66.7)

 

Western Europe

49 (35.5)

10 (17.2)

4 (14.3)

32 (94.1)

1 (11.1)

2 (22.2)

 

Africa

14 (101)

4 (6.9)

10 (35.7)

-

-

-

 

South America

7 (5.1)

2 (3.4)

1 (3.6)

2 (5.9)

1 (11.1)

1 (11.1)

 

Asia

22 (15.9)

11 (19.0)

8 (28.6)

-

3 (33.3)

-

 

BCG

      

< 0.0001

BCG-positive

61 (44.2)

39 (67.2)

14 (50.0)

6 (17.6)

1 (11.1)

2 (22.2)

 

BCG-negative

57 (41.3)

10 (17.2)

4 (14.3)

28 (82.4)

8 (88.9)

7 (77.8)

 

BCG-unknown

19 (15.8)

9 (15.5)

10 (35.7)

-

   

Pulmonary TB

microbiological diagnosis

-

48 (82.8)

-

-

9 (100.0)

9 (100.0)

 

Pulmonary TB

clinical diagnosis

-

10 (17.2)

-

-

   

Pulmonary diseases

other than TB

       

Pneumonia

-

-

16 (57.1)

-

   

Cancer

-

-

2 (7.1)

-

   

Bronchitis

-

-

3 (10.7)

-

   

COPD*

-

-

6 (21.4)

-

   

Pleural effusion

not TB related

-

-

1 (3.6)

-

   

Mean Bacteriuria

(SD)

1770

(1632)

1911

(1988)

1944

(1446)

1346

(787)

685

(830)

2347

(1817)

=0.352

HIV status

      

=0.118

HIV-positive

4 (2.9)

1 (1.7)

2 (7.1)

-

1 (11.1)

-

 

HIV-negative

126 (91.3)

55 (94.8)

23 (82.1)

34 (100.0)

5 (55.6)

9 (100.0)

 

HIV-unknown

8 (5.8)

2 (3.4)

3 (10.7)

-

3 (33.3)

-

 
  1. TB: tuberculosis; HIV: human immunodeficiency virus; SD: standard deviation; BCG: Bacillus Calmètte et Guerin; COPD: chronic obstructive pulmonary diseases.